URS
ROIV icon

Utah Retirement Systems’s Roivant Sciences ROIV Stock Holding History

Utah Retirement Systems’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$903K Buy
25,527
+2,978
+13% +$88K 0.01% 684
2026
Q1 		$625K Buy
22,549
+1,923
+9% +$49.4K 0.01% 707
2025
Q4 		$448K Hold
20,626
– – ﹤0.01% 776
2025
Q3 		$312K Buy
20,626
+600
+3% +$7.43K ﹤0.01% 874
2025
Q2 		$226K Sell
20,026
-2,774
-12% -$30.1K ﹤0.01% 948
2025
Q1 		$230K Hold
22,800
– – ﹤0.01% 913
2024
Q4 		$270K Hold
22,800
– – ﹤0.01% 904
2024
Q3 		$263K Buy
22,800
+4,000
+21% +$45.5K ﹤0.01% 921
2024
Q2 		$199K Sell
18,800
-1,300
-6% -$14.2K ﹤0.01% 951
2024
Q1 		$212K Buy
20,100
+400
+2% +$4.31K ﹤0.01% 934
2023
Q4 		$221K Buy
19,700
+800
+4% +$7.8K ﹤0.01% 942
2023
Q3 		$221K Buy
18,900
+5,700
+43% +$64.4K ﹤0.01% 913
2023
Q2 		$133K Buy
+13,200
New +$118K ﹤0.01% 976

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Utah Retirement Systems's ROIV Position: Q2 2026 in Review

Utah Retirement Systems increased its Roivant Sciences (ROIV) stake by 13% in Q2 2026, buying an estimated $88K and bringing the position to 25,527 shares worth $903K. The position accounts for 0.01% of the portfolio, ranked #684.

Utah Retirement Systems first reported a position in ROIV in Q2 2023 and has held it in 13 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Utah Retirement Systems held 25,527 shares of Roivant Sciences worth $903K as of Q2 2026.
  • Utah Retirement Systems bought 2,978 Roivant Sciences shares in Q2 2026, an estimated $88K.
  • Roivant Sciences made up 0.01% of Utah Retirement Systems's portfolio in Q2 2026, its #684 holding.
  • Utah Retirement Systems first reported a position in Roivant Sciences in Q2 2023 and has held it in 13 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Utah Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.